GKSD Investment Holding SA (‘GKSD’), a company backed by Italian Healthcare organisation Gruppo Ospedaliero San Donato (GSD), considers healthcare as a key strategic sector for global investments. GKSD believes that strategic investments in health not only deliver better health services and improve well-being, but also helps economies, creates jobs, and enhances the quality of life. Investing in healthcare is a vital economic and societal catalyst and a key focus for the group.

GKSD is owned by sponsors of Gruppo Ospedaliero San Donato (GSD) and is the largest private Italian healthcare provider. Together with GK Investment Holding Group, it is focussed on expanding the international network of healthcare services provided by GSD. In this respect, a number of initiatives are underway.

GSD (founded in 1957) is the leading accredited private hospital operator in Italy by revenue and one of the largest hospital groups in Europe. GSD’s operations include 44 clinics and hospitals in Lombardy and Emilia Romagna, totalling over c.5,500 beds. GSD has c.21,000 employees including 8,000 doctors, 10,000 nurses and 3,000 administrative staff offering clinical excellence to c.5m patients per year and owns the vast majority of its real estate portfolio.

GSD is the principal centre for medical research in Italy, hosting renowned medical universities and providing a complete set of medical, academic and research activities. In 2018 GSD was responsible for c.1,500 scientific publications relating to biomedicine. Given the group’s familiarity with the healthcare industry, access to operational resources, a leading medical research platform and highly experienced executive leadership, the group is uniquely positioned in this regard to assist with the development of GCC’s healthcare system and stabilise strategic healthcare assets for regional development and beyond.

The Group has four research institutes, three of which are University hospitals. The flagship Ospedale San Raffaele in Milan is not only the first hospital ranked for the quality of clinical services by the Italian Ministry of Health but is also the first research institute in Italy as per volume and profile of scientific output: in 2018 alone the institute produced 1,446 scientific publications with a total impact factor of 8.545. GSD also comprises the Policlinico San Donato, which hosts the medical school Università degli Studi di Milano and the Vita-Salute San Raffaele University.

In emerging markets, increasing the sustainability of healthcare provision for every citizen is vital. Through GKSD, added value can be achieved through enhanced in-country hospital management and training/rotation programmes with the GSD sites in Italy. It will also be possible to extend state-of-the-art medical services and provide experience in handling the complex demands that are critical for large healthcare providers. Further critical support will come from education, research and diagnostics across every spectrum of care.

As Vice President of Gruppo Ospedaliero San Donato, Chairman of GSD Middle East and Chairman GK Investment Holding SA, Mr. Kamel Ghribi’s principal aim has been to help the GSD brand grow and expand in the Middle East through strategic development initiatives in the region as well establishing a presence and raising the profile of the group through technical exchange and medical training programmes as well as research and development.

In 2019 GSD reported revenues of c. €1.7Bn.